Form 6-K SINOVAC BIOTECH LTD For: Nov 17
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall St climbs as oil slips; SpaceX spectrum deal weighs on telecoms
- Oil falls as Trump comments on Iran talks ease supply concerns
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment deteriorates further in October
- CoreWeave stock drops on dilution fears and debt concerns
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
- Anthropic launches cyber defense program for infrastructure and open-source
Sinovac Biotech (SVA) Posts Breakeven Q3 Loss
November 17, 2014 9:27 AM ESTSinovac Biotech (NASDAQ: SVA) reported Q3 EPS of $0.00, versus $0.04 reported last year. Revenue for the quarter came in at $17.1 million, versus $22.1 million reported last year.
For earnings history and earnings-related data on Sinovac Biotech (SVA) click here.
... More


